CA2384448C - Method of treatment of seborrheic dermatitis - Google Patents

Method of treatment of seborrheic dermatitis Download PDF

Info

Publication number
CA2384448C
CA2384448C CA002384448A CA2384448A CA2384448C CA 2384448 C CA2384448 C CA 2384448C CA 002384448 A CA002384448 A CA 002384448A CA 2384448 A CA2384448 A CA 2384448A CA 2384448 C CA2384448 C CA 2384448C
Authority
CA
Canada
Prior art keywords
ivermectin
treatment
seborrheic dermatitis
pharmaceutically acceptable
lotion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002384448A
Other languages
English (en)
French (fr)
Other versions
CA2384448A1 (en
Inventor
L. Parks Dean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2384448A1 publication Critical patent/CA2384448A1/en
Application granted granted Critical
Publication of CA2384448C publication Critical patent/CA2384448C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002384448A 2000-06-29 2001-06-27 Method of treatment of seborrheic dermatitis Expired - Fee Related CA2384448C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/605,747 US6319945B1 (en) 2000-06-29 2000-06-29 Method of treatment of seborrheic dermatitis
US09/605,747 2000-06-29
PCT/US2001/041159 WO2002002056A2 (en) 2000-06-29 2001-06-27 Method of treatment of seborrheic dermatitis

Publications (2)

Publication Number Publication Date
CA2384448A1 CA2384448A1 (en) 2002-01-10
CA2384448C true CA2384448C (en) 2008-09-16

Family

ID=24425042

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002384448A Expired - Fee Related CA2384448C (en) 2000-06-29 2001-06-27 Method of treatment of seborrheic dermatitis

Country Status (10)

Country Link
US (2) US6319945B1 (cg-RX-API-DMAC7.html)
EP (1) EP1294375B1 (cg-RX-API-DMAC7.html)
JP (1) JP3802485B2 (cg-RX-API-DMAC7.html)
CN (1) CN1171588C (cg-RX-API-DMAC7.html)
AT (1) ATE314068T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002216748A1 (cg-RX-API-DMAC7.html)
CA (1) CA2384448C (cg-RX-API-DMAC7.html)
DE (1) DE60116302T2 (cg-RX-API-DMAC7.html)
ES (1) ES2252312T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002002056A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
KR101186271B1 (ko) 2002-06-26 2012-09-27 애버리 데니슨 코포레이션 폴리프로필렌/올레핀 탄성체 혼합물을 포함하는 배향된필름
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
WO2004093886A1 (en) * 2003-04-24 2004-11-04 Galderma S.A. Topical formulation of ivermectin for the treatment of dermatological conditions
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
US9662867B2 (en) 2006-06-14 2017-05-30 Avery Dennison Corporation Conformable and die-cuttable machine direction oriented labelstocks and labels, and process for preparing
WO2007149900A2 (en) 2006-06-20 2007-12-27 Avery Dennison Corporation Multilayered polymeric film for hot melt adhesive labeling and label stock and label thereof
CA2666365C (en) * 2006-10-12 2016-08-09 Topaz Pharmaceuticals Llc Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
WO2012054328A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating hemorrhoids using macrocyclic lactone compound
EP2629770B1 (en) 2010-10-20 2016-05-25 Galderma S.A. Ivermectin for use in treating otitis externa
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233117B2 (en) 2013-07-08 2016-01-12 Galderma S. A. Treatment of inflammatory lesions of rosacea with ivermectin
US11459488B2 (en) 2014-06-02 2022-10-04 Avery Dennison Corporation Films with enhanced scuff resistance, clarity, and conformability
CN110604741A (zh) * 2018-06-15 2019-12-24 瑞恩生化科技有限公司 抑制皮肤细胞增生的组合物及其应用
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5877295A (en) * 1992-09-30 1999-03-02 The Center For Blood Research Antibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
DE4328689A1 (de) * 1993-08-26 1995-03-02 Beiersdorf Ag Verfahren zur Detektion und Zählung von Mikroorganismen
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
DE69739215D1 (de) * 1996-05-20 2009-03-05 Otsuka Pharma Co Ltd Heilmittel fuer rosazla
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
KR100315465B1 (ko) * 1998-11-23 2002-02-19 성재갑 수용성고분자와알코올을포함하는주사제용동물구충제조성물

Also Published As

Publication number Publication date
DE60116302D1 (de) 2006-02-02
EP1294375B1 (en) 2005-12-28
CA2384448A1 (en) 2002-01-10
EP1294375A4 (en) 2004-06-09
ES2252312T3 (es) 2006-05-16
ATE314068T1 (de) 2006-01-15
CN1171588C (zh) 2004-10-20
WO2002002056A2 (en) 2002-01-10
US6433006B2 (en) 2002-08-13
JP3802485B2 (ja) 2006-07-26
US6319945B1 (en) 2001-11-20
US20020019354A1 (en) 2002-02-14
WO2002002056A3 (en) 2002-03-28
DE60116302T2 (de) 2006-08-10
AU2002216748A1 (en) 2002-01-14
EP1294375A2 (en) 2003-03-26
CN1383379A (zh) 2002-12-04
JP2004501939A (ja) 2004-01-22

Similar Documents

Publication Publication Date Title
EP1294375B1 (en) Treatment of seborrheic dermatitis
EP1439832B1 (en) Method of treating acne vulgaris using avermectin compound
CA1279576C (en) Treatment of skin disorders
DE60027455T2 (de) Oligosaccharidealdonsäure und ihre topische verabreichung
US6399651B1 (en) Method of treating dermatoses using avermectin compound
EP3192507B1 (de) Verwendung von kombinationspräparaten, umfassend antimykotika
JPH10509437A (ja) 防臭、抗菌及び保存剤組成物並びにそれらを使用する方法
DE69818806T2 (de) Antimikrobielle kosmetische präparate
US4132781A (en) Method for treatment of acne
US5674539A (en) Method of treating skin and composition
US20040167084A1 (en) Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US5667790A (en) Aluminum chlorhydrate as a treatment for acne and rosacea
DE2557431A1 (de) Topische antimikrobielle praeparate
Ive An overview of experience with ketoconazole shampoo
WO2022153308A1 (en) Topical composition
US6465446B1 (en) Treatment of dermatitis by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof
Greaves et al. Topical corticosteroids
CN1748707A (zh) 伊维菌素在脂溢性皮炎治疗中的治疗应用及应用方法
EP2387396B1 (de) Mittel zur vorbeugung und behandlung der pityriasis versicolor
EP3189829A1 (de) Mittel mit anti-mykotischer wirkung
JP2000026301A (ja) 皮膚疾患治療薬
Raval et al. Topical therapy in neonates
Raab Combined Use of Imidazole Derivatives and Glucocorticoids for the Local Treatment of Skin Disease
DE102009004959A1 (de) Mittel zur Vorbeugung und Behandlung der Pityriasis versicolor

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160627